×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ENZ – enzo biochem, inc. ($0.01 par value) (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ENZ
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
03:07 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Neutral
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
11/7
02:03 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
10/30
02:07 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
10/29
07:59 pm
enz
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
Low
Report
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2024 Results and Announces Cash Dividend
10/22
02:02 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
10/14
02:18 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
10/6
02:01 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
9/28
02:01 am
enz
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/30
06:02 am
enz
Form 8-K ENZO BIOCHEM INC For: Oct 29
Low
Report
Form 8-K ENZO BIOCHEM INC For: Oct 29
10/29
05:05 pm
enz
Form 10-K ENZO BIOCHEM INC For: Jul 31
Low
Report
Form 10-K ENZO BIOCHEM INC For: Jul 31
9/24
05:19 pm
enz
Form 8-K ENZO BIOCHEM INC For: Sep 20
Neutral
Report
Form 8-K ENZO BIOCHEM INC For: Sep 20
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/5
Q2/2020 1/31/2020 EPS -0.120 ZacksConsensus N/A ActVsEst N/A - N/A
50.4%
3/20 Coronavirus live updates: How the New York elite got tested, Coca-Cola pulls its 2020 outlook [CNBC] 19.3%
6/10 Form 10-Q ENZO BIOCHEM INC For: Apr 30 18.5%
3/6 Form S-8 ENZO BIOCHEM INC 13.8%
7/24 Form SC 13D/A ENZO BIOCHEM INC Filed by: Harbert Discovery Fund, LP 12.9%
4/24 Form 8-K ENZO BIOCHEM INC For: Apr 23 10.4%
6/11 Enzo Biochem, Inc. (ENZ) Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 8.3%
8/5 Form 8-K ENZO BIOCHEM INC For: Aug 05 8.0%
2/25 Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting 6.7%
6/28 Form 11-K ENZO BIOCHEM INC For: Dec 31 5.7%
3/20 Coronavirus live updates: How the New York elite got tested, Coca-Cola pulls its 2020 outlook [CNBC] 19.3%
6/10 Form 10-Q ENZO BIOCHEM INC For: Apr 30 18.5%
3/6 Form S-8 ENZO BIOCHEM INC 13.8%
7/24 Form SC 13D/A ENZO BIOCHEM INC Filed by: Harbert Discovery Fund, LP 12.9%
4/24 Form 8-K ENZO BIOCHEM INC For: Apr 23 10.4%
6/11 Enzo Biochem, Inc. (ENZ) Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 8.3%
8/5 Form 8-K ENZO BIOCHEM INC For: Aug 05 8.0%
2/25 Enzo Biochem Announces Preliminary Results of Voting at Annual Shareholder Meeting 6.7%
6/28 Form 11-K ENZO BIOCHEM INC For: Dec 31 5.7%
TOP News Decliners
4/29
Enzo Announces Issuance of U.S. Patent for Methods of Using Proprietary Compound SK1-I in Patients; Exploring Options for Development as a Potential Treatment for COVID-19
-24.8%
4/23 Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization -24.3%
12/10 Form 8-K ENZO BIOCHEM INC For: Dec 10 -10.7%
4/29 Form 4/A ENZO BIOCHEM INC For: Apr 23 Filed by: CLEMENS PETER J IV -9.0%
4/9 Form 8-K ENZO BIOCHEM INC For: Apr 09 -8.6%
5/20 Form SC 13D/A ENZO BIOCHEM INC Filed by: Harbert Discovery Fund, LP -8.0%
8/5 Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications -7.7%
2/25 Form 8-K ENZO BIOCHEM INC For: Feb 25 -7.1%
4/14 Form 8-K/A ENZO BIOCHEM INC For: Apr 09 -6.6%
7/25 Form SC 13D/A ENZO BIOCHEM INC Filed by: Roumell Asset Management, LLC -6.1%
4/23 Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization -24.3%
12/10 Form 8-K ENZO BIOCHEM INC For: Dec 10 -10.7%
4/29 Form 4/A ENZO BIOCHEM INC For: Apr 23 Filed by: CLEMENS PETER J IV -9.0%
4/9 Form 8-K ENZO BIOCHEM INC For: Apr 09 -8.6%
5/20 Form SC 13D/A ENZO BIOCHEM INC Filed by: Harbert Discovery Fund, LP -8.0%
8/5 Enzo Biochem, Inc. Announces Issuance of United States Patent for Advanced Nucleic Acid Hybridization Probe Technology for Clinical and Research Applications -7.7%
2/25 Form 8-K ENZO BIOCHEM INC For: Feb 25 -7.1%
4/14 Form 8-K/A ENZO BIOCHEM INC For: Apr 09 -6.6%
7/25 Form SC 13D/A ENZO BIOCHEM INC Filed by: Roumell Asset Management, LLC -6.1%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: